iCare4: Genomic Signatures With Midostaurin in Acute Myeloid Leukemia (UF-HEM-004)

NCT03207334 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Insufficient funding

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Midostaurin
DRUG: Cytarabine

Sponsor

University of Florida

Collaborators

[object Object]